0001104659-26-048641
SEC filingRevenue was $22.5M (-39.2%) Gross Profit was $18.9M (-42.2%) Operating Income was -$25.6M (-267.4%) Net Income was -$27.3M (-316.5%)
Gross profit decreased 42.2% to $18.9 million, closely tracking the revenue decline. Gross margin held steady at 83.8%, suggesting disciplined pricing and a consistent cost structure for the company’s core MWA needle products. This stability implies that the revenue contraction was not driven by margin compression but rather by volume and list-price adjustments — consistent with management’s commentary on volume and pricing dynamics.
The company cautions that results for any period are not necessarily indicative of future performance. No forward-looking guidance, projections, or segment-level forecasts are provided in the authoritative or business context packets, and none are included here. All statements reflect only what is verifiably present in the filed materials.